Found in translation: integrated approaches to drug development

Area of Science:

• Pharmacology and Toxicology
• Drug Development
• Biomedical Research

Background:

• The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) held its 44th Annual Scientific Meeting in Melbourne.
• The conference theme was 'Found in translation: integrated approaches to drug development', emphasizing the transition of research into clinical applications.
• The meeting convened from 28 November to 1 December 2010.

Framework:

• The conference served as a platform for disseminating recent advancements in pharmacological and toxicological research.
• Discussions highlighted the integration of diverse scientific approaches for effective drug development.
• Presentations covered both novel therapeutic agents and innovative drug targets.

Implementation:

• New drug candidates discussed included dynamin inhibitors, Xen2174 (an oxytocin receptor agonist), and annexin-A12-26.
• Emerging drug targets identified were B7-dependent costimulation, chemoattractant receptors, granulocyte-macrophage colony-stimulating factor, and glutathione peroxidases.
• The meeting facilitated knowledge exchange among researchers and clinicians in the field.

Implications:

• The identified drug targets and novel therapeutics represent potential avenues for future pharmaceutical innovation.
• The integrated approaches discussed aim to streamline the drug development pipeline.
• Findings from the meeting contribute to the broader understanding of drug action and disease treatment strategies.